As of 2026-03-23, the Relative Valuation of Keros Therapeutics Inc (KROS) is 103.95 USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.96 USD, the upside of Keros Therapeutics Inc based on Relative Valuation is 848.4%.
The range of the Relative Valuation is 89.29 - 128.28 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 28.2x | 24.3x |
| Forward P/E multiples | 20.7x - 26.9x | 21.8x |
| Fair Price | 89.29 - 128.28 | 103.95 |
| Upside | 714.7% - 1070.4% | 848.4% |
| Date | P/E |
| 2026-03-18 | 2.56 |
| 2026-03-17 | 2.65 |
| 2026-03-16 | 2.58 |
| 2026-03-13 | 2.57 |
| 2026-03-12 | 2.57 |
| 2026-03-11 | 2.63 |
| 2026-03-10 | 2.71 |
| 2026-03-09 | 2.65 |
| 2026-03-06 | 2.64 |
| 2026-03-05 | 2.74 |
| 2026-03-04 | 3.22 |
| 2026-03-03 | 3.13 |
| 2026-03-02 | 3.25 |
| 2026-02-27 | 3.32 |
| 2026-02-26 | 3.51 |
| 2026-02-25 | 3.56 |
| 2026-02-24 | 3.63 |
| 2026-02-23 | 3.67 |
| 2026-02-20 | 3.78 |
| 2026-02-19 | 3.87 |
| 2026-02-18 | 3.78 |
| 2026-02-17 | 3.86 |
| 2026-02-13 | 3.87 |
| 2026-02-12 | 3.88 |
| 2026-02-11 | 3.98 |
| 2026-02-10 | 4.01 |
| 2026-02-09 | 4.10 |
| 2026-02-06 | 4.10 |
| 2026-02-05 | 4.03 |
| 2026-02-04 | 4.22 |
| 2026-02-03 | 4.32 |
| 2026-02-02 | 4.30 |
| 2026-01-30 | 4.18 |
| 2026-01-29 | 4.20 |
| 2026-01-28 | 4.17 |
| 2026-01-27 | 4.28 |
| 2026-01-26 | 4.39 |
| 2026-01-23 | 4.49 |
| 2026-01-22 | 4.55 |
| 2026-01-21 | 4.44 |
| 2026-01-20 | 4.31 |
| 2026-01-16 | 4.41 |
| 2026-01-15 | 4.50 |
| 2026-01-14 | 4.56 |
| 2026-01-13 | 4.56 |
| 2026-01-12 | 4.41 |
| 2026-01-09 | 4.49 |
| 2026-01-08 | 4.34 |
| 2026-01-07 | 4.34 |
| 2026-01-06 | 4.16 |